Medicine recalls
|
| |
| Singapore: Voluntary Recall of Iliadin Solution 0.025%, Iliadin Solution 0.05%, Iliadin Spray 0.05%, Iliadin Solution for Nose 0.01% due to isolated instances of microbiological impurities being identified near the end of the products' shelf life or upon expiry |
| |
HSA announced that Merck would like to inform healthcare professionals of the voluntary recall of selected batches of Iliadin Solution 0.025%, Iliadin Solution 0.05%, Iliadin Spray 0.05% and Iliadin Solution for Nose 0.01% due to isolated instances of microbiological impurities being identified near the end of the products' shelf life or upon expiry. During routine testing, isolated instances of microbiological impurities were identified in a few batches of Iliadin products manufactured before June 2012. A review of the manufacturing and steaming operation of the filling tank had identified the source of microbial impurities to be purified water used for chilling of the filling tank, of which a possible back flow into the filling tank may have resulted in the contamination. As a precautionary measure, Merck is initiating an immediate voluntary recall of all batches of Iliadin Solution 0.025%, Iliadin Solution 0.05%, Iliadin Spray 0.05% and Iliadin Solution for Nose 0.01% manufactured before June 2012.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/publish/hsaportal/../DHCPL.html
In Hong Kong, one Iliadin product, namely Iliadin Nasal Spray 0.05% (HK-10170), is registered by Merck Pharmaceutical (HK) Limited (Merck). So far, the Department of Health has not received any adverse drug reaction reports related to the product. Confirmed with Merck, the product has not been imported into Hong Kong since May 2010 and the goods imported before May 2010 were expired.
Ends/ Wednesday, February 06, 2013
Issued at HKT 16:30
|
| |
